Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression
Weibo Luo(Southwestern Medical Center), Gregg L. Semenza(Johns Hopkins University)
Cited by 228
Related Papers
FIH-1: a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity
|Genes & Development|2001|1.4k
HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
|Journal of Clinical Investigation|2013|1.3k
Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m <sup>6</sup> A-demethylation of NANOG mRNA
|Proceedings of the National Academy of Sciences|2016|1k
HIF-1 and human disease: one highly involved factor
|Genes & Development|2000|916